Double-blind, parallel, randomized pilot study comparing the efficacy and tolerance of cetiririne 10 mg, mequitazine 2 x 5 mg and placebo in the treatment of patients suffering from chronic urticaria: Comparison of suppressive effects on histamine-induced weals and flares

Drug Development Research

Volumn 43, Issue 4, 1998, Pages 185-192

  Abu Shareeah, Ahmed M ^a   Youssuf, Mohammed ^b   Deckers, Ilse ^c   De Mahieu, Cédric ^d   Coulie, P J ^c  

^a MAFRAQ HOSPITAL   (United Arab Emirates)

^b Modern Pharmaceutical Co   (United Arab Emirates)

^c UCB PHARMA   (Belgium)

^d Medical Affairs ^*

Author keywords

Cetirizine; Chronic urticaria; Mequitazine

Indexed keywords

CETIRIZINE; MEQUITAZINE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CHRONIC URTICARIA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ERYTHEMA; HUMAN; ORAL DRUG ADMINISTRATION; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; URTICARIA;

EID: 0031849875     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199804)43:4<185::AID-DDR1>3.0.CO;2-E     Document Type: Article

References (24)

1. Abu Shareeah AM (1992): Comparative efficacy of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Int J Dermatol 31:355-356.
2. Alomar A, De La Cuadra J, Fernandez J (1990): Cetirizine vs astemizole in the treatment of chronic idiopathic urticaria. J Int Med Res 18:358-365.
3. Bousquet J, Duchateau J, Pignat JC, Fayol C, Marquis P, Mariz S, Ware JE, Valentin B, Burtin B (1996): Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 98:309-316.
4. Brandon ML (1985): Newer non-sedating antihistamines will they replace older agents? Drugs 30:377-381.
5. Campoli-Richards DM, Buckley MM-T, Fitton A (1990): Cetirizine: A review of its pharmacological properties and clinical potential in allergic rhinitus, pollen-induced asthma and chronic urticaria. Drugs 40:762-781.
6. Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM (1989): Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 83:905-912.
7. Fadel R, Herpin-Richard N, Henocq E, Rihoux JP (1987): Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy 17:373-379.
8. Hannuksela M, Kalimo K, Lammintausta K, Mattila T (1993): Doseranging study: Cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy 70:127-133.
9. 1-receptor antagonists as assessed by the induced wheal-and-flare model. Allergy 50:24-30.
10. Juhlin L, Arendt C (1988): Treatment of chronic urticaria with cetirizine dihydrochloride, a non-sedating antihistamine. Br J Dermatol 119:67-72.
11. Kalivas J, Breneman D, Tharp M, Bruce S, Bigby M, et al (1990): Urticaria: Clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J Allergy Clin Immunol 86:1014-1018.
12. Kietzmann H, Macher E, Rihoux JP, Ghys L (1990) Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 65:498-500.
13. Kint A, Constandt L, Arendt C, Bernheim J, Aroni K (1989): Comparative efficacy of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria. Acta Ther 15:65-75.
14. Kontou-Fili K, Maniatakou G, Demaka P, Gonianakis M, Palaiologos G (1991): Therapeutic effects of cetirizine in delayed pressure urticaria: Clinicopathologic findings. J Am Acad Dermatol 24:1090-1093.
15. Mattews K (1983): Urticaria and angioedema. J Allergy Clin Immunol 72:1-14.
16. Michel L, De Vos C, Rihoux JP, Burtin C, Bienveniste J, Dubertret L (1988): Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 82:101-109.
17. Paul E, Fuehrer T, Boedeker RH (1989): Comparison of the effect of four non-sedating antihistamines on the histamine-induced wheal and flare response in human skin. Allergy 43:Suppl 7:95.
18. Revuz J, Gabison G, Michaut S (1989): Anti-degranulant action of mequitazine in a cutaneous model. J Invest Dermatol 92:143.
19. Rihoux JP, Dupont P (1987): Comparative study of the peripheral and central effects of terfenadine and cetirizine 2HCl. Ann Allergy 59:235-238.
20. 1 inhibiting effects of cetirizine 2HCl and loratadine. Ann Allergy 65:139-142.
21. Sidiropoulos J, Volonakis M, Kontou-Fili K (1988): Inhibition of histamine-induced weal and flare reactions by cetirizine 2HCl and mequitazine both in healthy and atopic subjects: A comparative double-blind placebo-controlled study. Epith Klin Farmakol Kaj Pharmacokinet 2:110-120.
22. Simons FER, McMillan JL, Simons KJ (1990): A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: Suppressive effects on histamine-induced weals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 86: 540-547.
23. Snyder SH, Snowman AM (1987): Receptor effects of cetirizine. Ann Allergy 59:4-8.
24. Vichyanond P, Jongpanichkultorn S, Aranyanark N, Tuchinda M (1991): Suppressive effects of histamine skin reactivity by a nonsedating antihistamine, mequitazine. Asian Pac J Allergy Immunol 9: 141-146.